AMCP Comments on PREVENT HPV Cancers Act
In today’s fast-changing health care environment, AMCP provides the tools and information you need to understand the issues and how they affect you and the patients you serve.
This session dives into the principles of pharmacoeconomics and how to integrate pharmacoeconomic principles in the drug evaluation process using real-world case studies. Gain hands-on experience to prepare for the P&T competition and learn more about the impact of pharmacoeconomics on managed care pharmacy.
In its second year, AMCP's annual Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy 2024 report looks at the fundamental concepts of managed care pharmacy and provides insight and clarity into how today's changing health care climate can be navigated to improve patient care and outcomes.
View the 2024 AAO Report to learn how managed care pharmacy professionals facilitate appropriate access to prescription treatments and promote affordability to help improve outcomes for patients across America’s health care system.
On October 2, 2024, the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) issued the Final Guidance for the Second Cycle of the Historic Medicare Drug Price Negotiation Program for Fiscal Year 2027.
On Oct. 1, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a set of frequently asked questions (FAQs) related to the Medicare Prescription Payment Plan.
In this video, Sean Riley from New Hampshire shares his health journey with amyloidosis, a rare genetic condition caused by mutations in certain genes that lead to the abnormal production of amyloid proteins.
On September 30, 2024, the Centers for Medicare and Medicaid Services (CMS) issued a Decision Memo titled “Final National Coverage Determination (NCD) for Pre-Exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Prevention”
